Lexeo Therapeutics Announces Positive Interim Data For
30, 2024, 05:25 am. Lxeo), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically. A phase i/ii study of lexeo therapeutics’ gene therapy to treat patients with alzheimer’s associated with the apoe4 genetic variant has achieved good interim results. Lxeo), a clinical stage genetic medicine company dedicated to pioneering.